# US 2020/0270634 A1 · Use of medea elements for biocontrol of d. suzukii populations

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0270634 A1
- Document ID: US20200270634A1
- Status: Published application
- Kind: A1
- Application number: 15/776,281
- Filed: 2017-01-25
- Published: 2020-08-27
- Earliest claimed: 2016-01-25
- Assignees: The Regents of the University of California
- Applicants: The Regents of the University of California
- Inventors: Omar S. AKBARI; Anne BUCHMAN
- Web page: https://patentgrep.com/patent/US20200270634A1

## CPC

- A01K 67/68: Genetically modified insects
- C12N 15/90: Stable introduction of foreign DNA into chromosome
- A01K 67/30: Rearing or breeding invertebrates
- C07K 14/43581: {from Drosophila}
- C12N 9/226: {Class 2 CAS enzyme complex, e.g. single CAS protein}
- C12N 15/113: Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)}
- C12N 15/8509: {for producing genetically modified animals, e.g. transgenic}
- A01K 2217/05: Animals comprising random inserted nucleic acids (transgenic)
- A01K 2217/052: inducing gain of function
- A01K 2217/30: Animal model comprising expression system for selective cell killing, e.g. toxins, enzyme dependent prodrug therapy using ganciclovir
- A01K 2227/706: Insects, e.g. Drosophila melanogaster, medfly
- A01K 2267/01: Animal expressing industrially exogenous proteins
- C07K 2319/55: containing a fusion with a toxin, e.g. diphteria toxin
- C12N 2310/141: MicroRNAs, miRNAs
- C12N 2310/20: involving clustered regularly interspaced short palindromic repeats [CRISPR]
- C12N 2830/008: cell type or tissue specific enhancer/promoter combination
- A01K: ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

An insect gene drive system for biocontrol of a population of an insect is provided. The gene drive system includes: a) a first DNA sequence encoding a toxin under the control of a maternal germline-specific promoter active in the insect, with the first DNA sequence being linked to b) a second DNA sequence encoding an antidote under the control of an early embryo-specific promoter active in the insect. The toxin is expressed in maternal germline cells of the insect and results in maternal-effect lethality in the insect, and the antidote is expressed in embryos of the insect and counters the maternal-effect lethality. In some embodiments, the insect is Drosophila suzrukii.

## Claims

### Claim 1

A gene drive system for biocontrol of a Drosophila suzukii population, comprising
a first DNA sequence encoding a toxin under the control of a maternal germline-specific promoter active in D. suzukii, and linked to
a second DNA sequence encoding an antidote under the control of an early embryo-specific promoter active in D. suzukii,
wherein the toxin is expressed in D. suzukii maternal germline cells and results in maternal-effect lethality in D. suzukii, and the antidote is expressed in D. suzukii embryos and counters the maternal-effect lethality.

### Claim 2 (depends on 1)

The gene drive system of claim 1, wherein the toxin comprises one or more miRNAs or RNA-guided endonucleases, or a combination thereof.

### Claim 3 (depends on 1)

The gene drive system of claim 1, wherein the toxin targets a gene for a D. suzukii maternally-deposited embryonic-essential RNA or protein.

### Claim 4 (depends on 3)

The gene drive system of claim 3, wherein the target gene is myd88.

### Claim 5 (depends on 3)

The gene drive system of claim 3, wherein the antidote is a toxin-resistant version of the target gene.

### Claim 6 (depends on 5)

The gene drive system of claim 5, wherein the toxin-resistant version is not recognized by the toxin.

### Claim 7 (depends on 1)

The gene drive system of claim 1, wherein the maternal germline-specific promoter is a bicoid promoter.

### Claim 8 (depends on 1)

The gene drive system of claim 1, wherein the early embryo-specific promoter is a bottleneck promoter

### Claim 9 (depends on 1)

The gene drive system of claim 1, further comprising an effector genetic element active in D. suzukii and linked to the first and second DNA sequences, wherein the effector genetic element encodes a gene conferring susceptability to a chemical, a conditional lethal gene, a genetic element that disrupts a recessive fertility gene or recessive lethality gene, or a genetic element that disrupts a gene involved in D. suzukii pest behavior.

### Claim 10 (depends on 1)

Transgenic D. suzukii having a genome comprising the gene drive system of claim 1.

### Claim 11 (depends on 9)

A method of manipulating a D. suzukii population, the method comprising releasing a transgenic D. suzukii having a genome comprising the gene drive system of claim 9 into the population in sufficient numbers to spread the gene drive system through the population.

### Claim 12 (depends on 11)

The method of claim 11, wherein the effector genetic element results in inducible lethality in one or both sexes of D. suzukii or results in recessive sterility in one or both sexes of D. suzukii.

### Claim 13 (depends on 10)

A method of manipulating a D. suzukii population, the method comprising releasing the transgenic D. suzukii of claim 10 into the population in sufficient numbers to spread the gene drive system through the population.

### Claim 14

A gene drive system for biocontrol of a population of an insect, comprising
a first DNA sequence encoding a toxin under the control of a maternal germline-specific promoter active in the insect, and linked to
a second DNA sequence encoding an antidote under the control of an early embryo-specific promoter active in the insect,
wherein the toxin is expressed in maternal germline cells of the insect and results in maternal-effect lethality in the insect, and the antidote is expressed in embryos of the insect and counters the maternal-effect lethality, and
wherein the insect is not Drosophila melanogaster or a flour beetle.

### Claim 15 (depends on 14)

The gene drive system of claim 14, wherein the toxin is an miRNA or an endonuclease.

### Claim 16 (depends on 14)

The gene drive system of claim 14, wherein the toxin targets a gene for a maternally-deposited embryonic-essential RNA or protein of the insect.

### Claim 17 (depends on 16)

The gene drive system of claim 16, wherein the target gene is myd88.

### Claim 18 (depends on 16)

The gene drive system of claim 16, wherein the antidote is a toxin-resistant version of the target gene.

### Claim 19 (depends on 18)

The gene drive system of claim 18, wherein the toxin-resistant version is not recognized by the toxin.

### Claim 20 (depends on 14)

The gene drive system of claim 14, further comprising an effector genetic element active in the insect and linked to the first and second DNA sequences, wherein the effector genetic element encodes a gene conferring susceptibility to a chemical, a conditional lethal gene, a genetic element that disrupts a recessive fertility gene or recessive lethality gene, or a genetic element that disrupts a gene involved in insect pest behavior.

### Claim 21 (depends on 14)

The gene drive system of claim 14, wherein the insect is Drosophila suzukii, Anastrepha suspensa, Anastrepha ludens, Anastrepha oblique, Bactrocera oleae/Dacus oleae, Ceratitis capitata, Aedes aegyptii, or Anopheles gambiae.

### Claim 22 (depends on 14)

A transgenic insect whose genome comprises the gene drive system of claim 14.

### Claim 23 (depends on 22)

A method of manipulating an insect population, the method comprising releasing the transgenic insect of claim 22 into a population of the same species in sufficient numbers to spread the gene drive system through the population.

### Claim 24 (depends on 20)

A method of manipulating an insect population, the method comprising releasing a transgenic insect having a gene drive system of claim 20 into a population of the same species in sufficient numbers to spread the gene drive system through the population, wherein the effector genetic element results in inducible lethality in one or both sexes of the species or results in recessive sterility in one or both sexes of the species.
